Promising vaccine developed that targets two types of Ebola, Marburg and Lassa virus
The Lassa virus (particles of which are pictured) is carried by rats native to Africa but can infect humans if they come into contact with the animal’s bodily fluids, and can spread rapidly between people by similar means. Although the virus is harmless to the rats, in people it causes a potentially fatal hemorrhagic fever. And, like two other infamous hemorrhagic fever viruses, Ebola and Marburg, Lassa is endemic in parts of Africa and a serious health threat. But a new broad-scope vaccine is set to tackle these deadly viruses en masse. The vaccine, which targets Lassa, two types of Ebola and Marburg has successfully immunised 20 macaque monkeys – none of the animals became sick when subsequently infected with the four viruses, while all unvaccinated control monkeys did. The result is an encouraging start toward a human version of the vaccine and, hopefully, the control of these pernicious pathogens.
Written by Ruth Williams
BPoD stands for Biomedical Picture of the Day. Managed by the MRC London Institute of Medical Sciences the website aims to engage everyone, young and old, in the wonders of biomedicine. Images are kindly provided for inclusion on this website through the generosity of scientists across the globe.
BPoD is also available in Catalan at www.bpod.cat with translations by the University of Valencia.